HLS Therapeutics Inc. (HLS.TO)
CAD 4.4
(0.92%)
CAD 4.4
(0.92%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 209.06 Million USD | -13.49% |
| 2022 | 241.65 Million USD | -12.41% |
| 2021 | 275.9 Million USD | -9.21% |
| 2020 | 303.9 Million USD | -4.93% |
| 2019 | 319.67 Million USD | 4.32% |
| 2018 | 306.42 Million USD | -20.34% |
| 2017 | 384.64 Million USD | 1406.99% |
| 2016 | 25.52 Million USD | -4.04% |
| 2015 | 26.59 Million USD | -55.79% |
| 2014 | 60.17 Million USD | 9.77% |
| 2013 | 54.81 Million USD | 10.34% |
| 2012 | 49.67 Million USD | 7.97% |
| 2011 | 46 Million USD | 1.34% |
| 2010 | 45.4 Million USD | -15.04% |
| 2009 | 53.43 Million USD | 16.52% |
| 2008 | 45.86 Million USD | -41.2% |
| 2007 | 77.99 Million USD | 58.37% |
| 2006 | 49.24 Million USD | 11.43% |
| 2005 | 44.19 Million USD | 47.42% |
| 2004 | 29.97 Million USD | -27.75% |
| 2003 | 41.49 Million USD | 44.89% |
| 2002 | 28.63 Million USD | -5.72% |
| 2001 | 30.37 Million USD | 18.76% |
| 2000 | 25.57 Million USD | -31.91% |
| 1999 | 37.56 Million USD | 35.03% |
| 1998 | 27.81 Million USD | -32.07% |
| 1997 | 40.95 Million USD | 122.55% |
| 1996 | 18.4 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 191.32 Million USD | -3.25% |
| 2024 Q1 | 197.75 Million USD | -5.41% |
| 2023 FY | 209.06 Million USD | -13.49% |
| 2023 Q1 | 234.15 Million USD | -3.1% |
| 2023 Q2 | 226.81 Million USD | -3.13% |
| 2023 Q3 | 215.22 Million USD | -5.11% |
| 2023 Q4 | 209.06 Million USD | -2.87% |
| 2022 FY | 241.65 Million USD | -12.41% |
| 2022 Q2 | 266.62 Million USD | -1.44% |
| 2022 Q1 | 270.52 Million USD | -1.95% |
| 2022 Q3 | 250.33 Million USD | -6.11% |
| 2022 Q4 | 241.65 Million USD | -3.47% |
| 2021 Q1 | 296.73 Million USD | -2.36% |
| 2021 FY | 275.9 Million USD | -9.21% |
| 2021 Q3 | 283.91 Million USD | -4.12% |
| 2021 Q4 | 275.9 Million USD | -2.82% |
| 2021 Q2 | 296.1 Million USD | -0.21% |
| 2020 Q1 | 306.4 Million USD | -4.15% |
| 2020 Q4 | 303.9 Million USD | -0.68% |
| 2020 FY | 303.9 Million USD | -4.93% |
| 2020 Q3 | 305.99 Million USD | 4.85% |
| 2020 Q2 | 291.83 Million USD | -4.76% |
| 2019 Q1 | 299.82 Million USD | -2.16% |
| 2019 Q4 | 319.67 Million USD | -1.14% |
| 2019 FY | 319.67 Million USD | 4.32% |
| 2019 Q2 | 334.71 Million USD | 11.64% |
| 2019 Q3 | 323.35 Million USD | -3.39% |
| 2018 FY | 306.42 Million USD | -20.34% |
| 2018 Q1 | 385.84 Million USD | 0.31% |
| 2018 Q2 | 368.05 Million USD | -4.61% |
| 2018 Q3 | 322.79 Million USD | -12.3% |
| 2018 Q4 | 306.42 Million USD | -5.07% |
| 2017 FY | 384.64 Million USD | 1406.99% |
| 2017 Q4 | 384.64 Million USD | 1327.53% |
| 2017 Q3 | 26.94 Million USD | 4.27% |
| 2017 Q2 | 25.84 Million USD | 1.73% |
| 2017 Q1 | 25.4 Million USD | -0.48% |
| 2016 Q2 | 27 Million USD | -0.82% |
| 2016 Q3 | 26.41 Million USD | -2.19% |
| 2016 Q4 | 25.52 Million USD | -3.36% |
| 2016 FY | 25.52 Million USD | -4.04% |
| 2016 Q1 | 27.22 Million USD | 2.35% |
| 2015 Q4 | 26.59 Million USD | -5.17% |
| 2015 Q2 | 43.04 Million USD | -4.92% |
| 2015 FY | 26.59 Million USD | -55.79% |
| 2015 Q3 | 28.04 Million USD | -34.84% |
| 2015 Q1 | 45.27 Million USD | -24.76% |
| 2014 FY | 60.17 Million USD | 9.77% |
| 2014 Q1 | 54.2 Million USD | -1.11% |
| 2014 Q3 | 62.14 Million USD | 2.64% |
| 2014 Q4 | 60.17 Million USD | -3.18% |
| 2014 Q2 | 60.55 Million USD | 11.71% |
| 2013 Q3 | 52.3 Million USD | 4.14% |
| 2013 FY | 54.81 Million USD | 10.34% |
| 2013 Q4 | 54.81 Million USD | 4.8% |
| 2013 Q2 | 50.22 Million USD | 1.8% |
| 2013 Q1 | 49.33 Million USD | -0.69% |
| 2012 Q4 | 49.67 Million USD | -19.06% |
| 2012 Q3 | 61.37 Million USD | 15.66% |
| 2012 FY | 49.67 Million USD | 7.97% |
| 2012 Q2 | 53.06 Million USD | 13.44% |
| 2012 Q1 | 46.77 Million USD | 1.67% |
| 2011 Q3 | 41.92 Million USD | -8.85% |
| 2011 Q2 | 45.99 Million USD | -2.52% |
| 2011 Q1 | 47.18 Million USD | 3.93% |
| 2011 FY | 46 Million USD | 1.34% |
| 2011 Q4 | 46 Million USD | 9.74% |
| 2010 Q2 | 52.99 Million USD | 10.46% |
| 2010 Q3 | 47.12 Million USD | -11.07% |
| 2010 Q4 | 45.4 Million USD | -3.65% |
| 2010 Q1 | 47.97 Million USD | -10.23% |
| 2010 FY | 45.4 Million USD | -15.04% |
| 2009 Q4 | 53.43 Million USD | 5.51% |
| 2009 FY | 53.43 Million USD | 16.52% |
| 2009 Q1 | 42.51 Million USD | -7.3% |
| 2009 Q2 | 48.79 Million USD | 14.78% |
| 2009 Q3 | 50.64 Million USD | 3.79% |
| 2008 FY | 45.86 Million USD | -41.2% |
| 2008 Q4 | 45.86 Million USD | -34.16% |
| 2008 Q1 | 73.16 Million USD | -6.18% |
| 2008 Q2 | 77.47 Million USD | 5.88% |
| 2008 Q3 | 69.65 Million USD | -10.09% |
| 2007 Q4 | 77.99 Million USD | 27.18% |
| 2007 Q2 | 55.47 Million USD | 5.15% |
| 2007 Q1 | 52.76 Million USD | 7.14% |
| 2007 FY | 77.99 Million USD | 58.37% |
| 2007 Q3 | 61.32 Million USD | 10.54% |
| 2006 FY | 49.24 Million USD | 11.43% |
| 2006 Q4 | 49.24 Million USD | 5.52% |
| 2006 Q3 | 46.66 Million USD | -2.95% |
| 2006 Q2 | 48.08 Million USD | 5.82% |
| 2006 Q1 | 45.44 Million USD | 2.82% |
| 2005 Q4 | 44.19 Million USD | 29.45% |
| 2005 Q3 | 34.14 Million USD | 12.55% |
| 2005 Q2 | 30.33 Million USD | 4.07% |
| 2005 Q1 | 29.14 Million USD | -2.77% |
| 2005 FY | 44.19 Million USD | 47.42% |
| 2004 Q1 | 42.62 Million USD | 2.73% |
| 2004 FY | 29.97 Million USD | -27.75% |
| 2004 Q3 | 39.77 Million USD | -2.24% |
| 2004 Q2 | 40.68 Million USD | -4.56% |
| 2004 Q4 | 29.97 Million USD | -24.62% |
| 2003 Q4 | 41.49 Million USD | -2.25% |
| 2003 FY | 41.49 Million USD | 44.89% |
| 2003 Q1 | 42.51 Million USD | 48.46% |
| 2003 Q2 | 42.85 Million USD | 0.82% |
| 2003 Q3 | 42.44 Million USD | -0.96% |
| 2002 Q4 | 28.63 Million USD | -0.25% |
| 2002 Q1 | 27.47 Million USD | -9.55% |
| 2002 Q2 | 29.17 Million USD | 6.2% |
| 2002 Q3 | 28.7 Million USD | -1.6% |
| 2002 FY | 28.63 Million USD | -5.72% |
| 2001 FY | 30.37 Million USD | 18.76% |
| 2001 Q1 | 22.95 Million USD | -10.23% |
| 2001 Q2 | 32.75 Million USD | 42.65% |
| 2001 Q3 | 32.12 Million USD | -1.91% |
| 2001 Q4 | 30.37 Million USD | -5.45% |
| 2000 Q3 | - USD | 0.0% |
| 2000 FY | 25.57 Million USD | -31.91% |
| 2000 Q1 | - USD | -100.0% |
| 2000 Q4 | 25.57 Million USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 FY | 37.56 Million USD | 35.03% |
| 1999 Q1 | - USD | -100.0% |
| 1999 Q4 | 37.56 Million USD | 0.0% |
| 1998 FY | 27.81 Million USD | -32.07% |
| 1998 Q4 | 27.81 Million USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 FY | 40.95 Million USD | 122.55% |
| 1997 Q1 | - USD | 0.0% |
| 1996 FY | 18.4 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aurora Cannabis Inc. | 838.67 Million CAD | 75.073% |
| Avicanna Inc. | 21.97 Million CAD | -851.522% |
| Avant Brands Inc. | 82.55 Million CAD | -153.246% |
| Cardiol Therapeutics Inc. | 36.7 Million CAD | -469.638% |
| Crescita Therapeutics Inc. | 24.59 Million CAD | -749.906% |
| Knight Therapeutics Inc. | 945.49 Million CAD | 77.889% |
| MediPharm Labs Corp. | 63.93 Million CAD | -226.978% |
| OrganiGram Holdings Inc. | 298.45 Million CAD | 29.953% |
| Canopy Growth Corporation | 1.3 Billion CAD | 83.923% |
| Willow Biosciences Inc. | 6.67 Million CAD | -3032.924% |
| Auxly Cannabis Group Inc. | 261.9 Million CAD | 20.177% |